Cobenfy Maintenance Effects on Cocaine Use Disorder
Part of Mental health clinical trials.
This study tests whether a medication called Cobenfy can reduce cocaine's effects in people with cocaine use disorder. Researchers will monitor your health and test how the medication impacts your response to cocaine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You use cocaine regularly (smoked or injected) and have a positive cocaine test during screening
- If you can get pregnant, you must use birth control throughout the study
- You speak and read English fluently
- Your heart, liver, and kidney function are within acceptable ranges
- You don't have serious heart problems, head injury with loss of consciousness, seizures, or serious mental health conditions
- You're not currently in treatment for substance use and don't misuse alcohol, opioids, or other drugs besides cocaine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research explores how certain brain chemicals (potassium channels) affect memory and thinking in people who use cocaine regularly. The study may help develop better treatments for cocaine use disorder and related thinking problems.
This trial combines deep transcranial magnetic stimulation (TMS) with a reward program (contingency management) to help people stop using cocaine. It may help if you are struggling with moderate to severe cocaine use and want a non-drug treatment.
This study tests whether a medication called pentoxifylline can reduce cocaine use in people who smoke or inject cocaine but aren't ready to stop. You'll receive either pentoxifylline or a placebo to see if it helps control cravings or use.
This study looks at how cravings for cocaine change over time in people who have recently stopped using. Researchers will measure brain activity to understand this process better.
This early-phase study uses brain imaging to understand how cocaine use disorder affects brain function. It may help researchers learn more about brain pathways involved in craving and treatment targets.
This study tests a new medication called Cobenfy (also known as trospium) using brain scans to see how it affects dopamine in people with schizophrenia. If you have schizophrenia and are not currently on antipsychotics, you may be able to join.
Hear when a new Cocaine Use Disorder (CUD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.